<p>Trexquant Investment LP 在最近向美國證券交易委員會提交的 13F 文件中表示，在第一季度將其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的持股減少了 54.5%。該基金在此期間出售了 262,607 股後，持有該公司 219,000 股股票。Trexquant Investment LP 在最近的報告期末持有的 Hims &amp; Hers Health 的股份約佔 0.10%，價值 6,471,000 美元。</p>
<p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
<ul>
<li>Ozempic 熱潮：Hims 和 Eli Lilly 引領醫療保健投資</li>
</ul>
<p>其他幾家機構投資者和對沖基金最近也對 HIMS 的持倉進行了調整。Farallon Capital Management LLC 在第四季度將其在 Hims &amp; Hers Health 的持倉提高了 64,338.5%。Farallon Capital Management LLC 目前持有該公司 8,377,000 股股票，價值 202,556,000 美元，此前在上個季度又增持了 8,364,000 股。Nuveen LLC 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 58,403,000 美元。Yong Rong HK Asset Management Ltd 在第一季度將其在 Hims &amp; Hers Health 的持倉提高了 41.2%。Yong Rong HK Asset Management Ltd 目前持有該公司 2,400,000 股股票，價值 70,920,000 美元，此前在上個季度又增持了 700,100 股。CloudAlpha Capital Management Limited Hong Kong 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 20,580,000 美元。最後，Jump Financial LLC 在第一季度將其在 Hims &amp; Hers Health 的持倉提高了 633.2%。Jump Financial LLC 目前持有該公司 725,445 股股票，價值 21,437,000 美元，此前在上個季度又增持了 626,496 股。機構投資者目前持有該公司 63.52% 的股份。</p>
<h2>華爾街分析師觀點</h2>
<p>幾位分析師對該股票發表了評論。Wall Street Zen 在 7 月 28 日的研究報告中將 Hims &amp; Hers Health 的股票評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。Zacks Research 在 8 月 19 日的研究報告中將 Hims &amp; Hers Health 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。瑞銀集團在 6 月 23 日的報告中對 Hims &amp; Hers Health 的股票設定了 30.00 美元的目標價。Piper Sandler 在 5 月 6 日的報告中重申了 &#34;中性&#34; 的評級，並將 Hims &amp; Hers Health 的目標價上調至 39.00 美元（之前為 35.00 美元）。最後，Needham &amp; Company LLC 在 8 月 5 日的報告中重申了 Hims &amp; Hers Health 的 &#34;持有&#34; 評級。兩位投資分析師對該股票給予了買入評級，八位分析師給予了持有評級，三位分析師給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;減持&#34;，平均目標價為 38.92 美元。</p>
<ul>
<li>內部人士在與 NVIDIA 相關的 Navitas、Hims 和 Shift4 中交易數百萬</li>
</ul>
<p><strong>查看我們關於 HIMS 的最新報告</strong></p>
<h2>Hims &amp; Hers Health 價格表現</h2>
<p>HIMS 股票在週五開盤價為 42.36 美元。Hims &amp; Hers Health, Inc. 的 12 個月低點為 13.47 美元，12 個月高點為 72.98 美元。該公司的市值為 95.7 億美元，市盈率為 52.95，市盈增長比率為 2.86，貝塔係數為 2.08。該公司的速動比率為 4.46，流動比率為 4.98，債務股本比率為 1.72。該公司的 50 日移動平均線為 49.98 美元，200 日移動平均線為 45.82 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 08/04 - 08/08</li>
</ul>
<p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近在 8 月 4 日星期一公佈了季度財報。該公司報告每股收益 (EPS) 為 0.17 美元，低於市場共識預期的 0.18 美元，差額為 0.01 美元。該公司在本季度的收入為 5.4483 億美元，而分析師預期為 5.5006 億美元。Hims &amp; Hers Health 的淨利潤率為 9.63%，股本回報率為 26.26%。Hims &amp; Hers Health 的季度收入同比增長 72.6%。去年同期，該公司每股收益為 0.06 美元。Hims &amp; Hers Health 已設定 2025 年第三季度的每股收益指導。2025 財年的每股收益指導。平均而言，股票研究分析師預測 Hims &amp; Hers Health, Inc. 今年將發佈 0.29 美元的每股收益。</p>
<h2>Hims &amp; Hers Health 的內部活動</h2>
<p>在相關消息中，內部人士 Patrick Harrison Carroll 於 8 月 6 日星期三出售了 60,000 股該公司的股票。股票以平均價格 53.58 美元出售，總價值為 3,214,800.00 美元。交易完成後，該內部人士直接持有該公司 169,940 股股票，價值約 9,105,385.20 美元。這代表其持股減少了 26.09%。該交易在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。此外，首席執行官 Andrew Dudum 於 8 月 7 日星期四出售了 660,000 股該公司的股票。股票以平均價格 50.58 美元出售，總交易額為 33,382,800.00 美元。交易完成後，首席執行官直接持有該公司 2,214,769 股股票，價值約 112,023,016.02 美元。該交易使其持股減少了 22.96%。該交易的披露信息可以在這裏找到。內部人士在上個季度共出售了 1,395,428 股公司股票，價值 71,753,898 美元。當前公司內部人士持有 13.71% 的股份。</p>
<h2>Hims &amp; Hers Health 概況</h2>
<p>(免費報告)</p>
<p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人員連接，使他們能夠獲得心理健康、性健康、皮膚病和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
<h2>特色文章</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Hims &amp; Hers Health</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>DICKS 體育用品公司的股票在財報發佈後下跌——這是一隻值得購買的股票嗎？</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
<li>AI 引擎：康明斯意外的增長驅動因素</li>
<li>除息日對投資者的重要性是什麼？</li>
<li>小型工業公司正在經歷快速增長：原因在這裏</li>
</ul>
<p><strong>想看看其他對 HIMS 感興趣的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Hims &amp; Hers Health 嗎？</h2>
<p>在考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 Hims &amp; Hers Health 並不在名單上。</p>
<p>雖然 Hims &amp; Hers Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HIMS

<p>Trexquant Investment LP 已將其在 Hims & Hers Health, Inc. 的持股比例減少了 54.5%，出售了 262,607 股，目前持有 219,000 股。該基金的持股價值約為 647 萬美元。其他機構投資者也調整了他們的持倉，其中 Farallon Capital Management 和 Jump Financial 的增持幅度顯著。分析師對 Hims & Hers Health 的評級意見不一，普遍評級為 “減持”，平均目標價為 38.92 美元。該股票開盤價為 42.36 美元，12 個月的價格區間為 13.47 美元至 72.98 美元</p>

<p>Trexquant Investment LP decreased its holdings in shares of Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report) by 54.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 219,000 shares of the company's stock after selling 262,607 shares during the period. Trexquant Investment LP owned approximately 0.10% of Hims &amp; Hers Health worth $6,471,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Trexquant Investment LP 在最近向美國證券交易委員會提交的 13F 文件中表示，在第一季度將其在 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的持股減少了 54.5%。該基金在此期間出售了 262,607 股後，持有該公司 219,000 股股票。Trexquant Investment LP 在最近的報告期末持有的 Hims &amp; Hers Health 的股份約佔 0.10%，價值 6,471,000 美元。</p>
</div><p>Get <strong>Hims &amp; Hers Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
</div><ul>
<li>Ozempic Boom: Hims &amp; Eli Lilly Lead Healthcare Bets</li>
</ul>
<div class="lb-trans"><ul>
<li>Ozempic 熱潮：Hims 和 Eli Lilly 引領醫療保健投資</li>
</ul>
</div><p>Several other institutional investors and hedge funds also recently made changes to their positions in HIMS. Farallon Capital Management LLC raised its position in shares of Hims &amp; Hers Health by 64,338.5% during the 4th quarter. Farallon Capital Management LLC now owns 8,377,000 shares of the company's stock valued at $202,556,000 after acquiring an additional 8,364,000 shares during the last quarter. Nuveen LLC bought a new stake in shares of Hims &amp; Hers Health during the 1st quarter valued at $58,403,000. Yong Rong HK Asset Management Ltd raised its position in shares of Hims &amp; Hers Health by 41.2% during the 1st quarter. Yong Rong HK Asset Management Ltd now owns 2,400,000 shares of the company's stock valued at $70,920,000 after acquiring an additional 700,100 shares during the last quarter. CloudAlpha Capital Management Limited Hong Kong bought a new stake in shares of Hims &amp; Hers Health during the 1st quarter valued at $20,580,000. Finally, Jump Financial LLC raised its position in shares of Hims &amp; Hers Health by 633.2% during the 1st quarter. Jump Financial LLC now owns 725,445 shares of the company's stock valued at $21,437,000 after acquiring an additional 626,496 shares during the last quarter. Institutional investors own 63.52% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金最近也對 HIMS 的持倉進行了調整。Farallon Capital Management LLC 在第四季度將其在 Hims &amp; Hers Health 的持倉提高了 64,338.5%。Farallon Capital Management LLC 目前持有該公司 8,377,000 股股票，價值 202,556,000 美元，此前在上個季度又增持了 8,364,000 股。Nuveen LLC 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 58,403,000 美元。Yong Rong HK Asset Management Ltd 在第一季度將其在 Hims &amp; Hers Health 的持倉提高了 41.2%。Yong Rong HK Asset Management Ltd 目前持有該公司 2,400,000 股股票，價值 70,920,000 美元，此前在上個季度又增持了 700,100 股。CloudAlpha Capital Management Limited Hong Kong 在第一季度購買了 Hims &amp; Hers Health 的新股份，價值 20,580,000 美元。最後，Jump Financial LLC 在第一季度將其在 Hims &amp; Hers Health 的持倉提高了 633.2%。Jump Financial LLC 目前持有該公司 725,445 股股票，價值 21,437,000 美元，此前在上個季度又增持了 626,496 股。機構投資者目前持有該公司 63.52% 的股份。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several analysts have commented on the stock. Wall Street Zen cut shares of Hims &amp; Hers Health from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, July 28th. Zacks Research cut shares of Hims &amp; Hers Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Tuesday, August 19th. UBS Group set a $30.00 price target on shares of Hims &amp; Hers Health in a report on Monday, June 23rd. Piper Sandler reissued a &#34;neutral&#34; rating and issued a $39.00 price target (up previously from $35.00) on shares of Hims &amp; Hers Health in a report on Tuesday, May 6th. Finally, Needham &amp; Company LLC reissued a &#34;hold&#34; rating on shares of Hims &amp; Hers Health in a report on Tuesday, August 5th. Two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of &#34;Reduce&#34; and an average price target of $38.92.</p>
<div class="lb-trans"><p>幾位分析師對該股票發表了評論。Wall Street Zen 在 7 月 28 日的研究報告中將 Hims &amp; Hers Health 的股票評級從 &#34;買入&#34; 下調至 &#34;持有&#34;。Zacks Research 在 8 月 19 日的研究報告中將 Hims &amp; Hers Health 的股票評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。瑞銀集團在 6 月 23 日的報告中對 Hims &amp; Hers Health 的股票設定了 30.00 美元的目標價。Piper Sandler 在 5 月 6 日的報告中重申了 &#34;中性&#34; 的評級，並將 Hims &amp; Hers Health 的目標價上調至 39.00 美元（之前為 35.00 美元）。最後，Needham &amp; Company LLC 在 8 月 5 日的報告中重申了 Hims &amp; Hers Health 的 &#34;持有&#34; 評級。兩位投資分析師對該股票給予了買入評級，八位分析師給予了持有評級，三位分析師給予了賣出評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;減持&#34;，平均目標價為 38.92 美元。</p>
</div><ul>
<li>Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, &amp; Shift4</li>
</ul>
<div class="lb-trans"><ul>
<li>內部人士在與 NVIDIA 相關的 Navitas、Hims 和 Shift4 中交易數百萬</li>
</ul>
</div><p><strong>Check Out Our Latest Report on HIMS</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 HIMS 的最新報告</strong></p>
</div><h2>Hims &amp; Hers Health Price Performance</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 價格表現</h2>
</div><p>Shares of HIMS stock opened at $42.36 on Friday. Hims &amp; Hers Health, Inc. has a 12-month low of $13.47 and a 12-month high of $72.98. The firm has a market capitalization of $9.57 billion, a price-to-earnings ratio of 52.95, a price-to-earnings-growth ratio of 2.86 and a beta of 2.08. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72. The firm has a fifty day moving average of $49.98 and a 200-day moving average of $45.82.</p>
<div class="lb-trans"><p>HIMS 股票在週五開盤價為 42.36 美元。Hims &amp; Hers Health, Inc. 的 12 個月低點為 13.47 美元，12 個月高點為 72.98 美元。該公司的市值為 95.7 億美元，市盈率為 52.95，市盈增長比率為 2.86，貝塔係數為 2.08。該公司的速動比率為 4.46，流動比率為 4.98，債務股本比率為 1.72。該公司的 50 日移動平均線為 49.98 美元，200 日移動平均線為 45.82 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 08/04 - 08/08</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 08/04 - 08/08</li>
</ul>
</div><p>Hims &amp; Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $544.83 million during the quarter, compared to analyst estimates of $550.06 million. Hims &amp; Hers Health had a net margin of 9.63% and a return on equity of 26.26%. Hims &amp; Hers Health's quarterly revenue was up 72.6% on a year-over-year basis. During the same period last year, the firm earned $0.06 EPS. Hims &amp; Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that Hims &amp; Hers Health, Inc. will post 0.29 earnings per share for the current year.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近在 8 月 4 日星期一公佈了季度財報。該公司報告每股收益 (EPS) 為 0.17 美元，低於市場共識預期的 0.18 美元，差額為 0.01 美元。該公司在本季度的收入為 5.4483 億美元，而分析師預期為 5.5006 億美元。Hims &amp; Hers Health 的淨利潤率為 9.63%，股本回報率為 26.26%。Hims &amp; Hers Health 的季度收入同比增長 72.6%。去年同期，該公司每股收益為 0.06 美元。Hims &amp; Hers Health 已設定 2025 年第三季度的每股收益指導。2025 財年的每股收益指導。平均而言，股票研究分析師預測 Hims &amp; Hers Health, Inc. 今年將發佈 0.29 美元的每股收益。</p>
</div><h2>Insider Activity at Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 的內部活動</h2>
</div><p>In related news, insider Patrick Harrison Carroll sold 60,000 shares of the company's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $53.58, for a total value of $3,214,800.00. Following the completion of the transaction, the insider directly owned 169,940 shares of the company's stock, valued at approximately $9,105,385.20. This represents a 26.09% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, CEO Andrew Dudum sold 660,000 shares of the company's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $50.58, for a total transaction of $33,382,800.00. Following the completion of the transaction, the chief executive officer directly owned 2,214,769 shares of the company's stock, valued at approximately $112,023,016.02. The trade was a 22.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,395,428 shares of company stock valued at $71,753,898 in the last quarter. 13.71% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，內部人士 Patrick Harrison Carroll 於 8 月 6 日星期三出售了 60,000 股該公司的股票。股票以平均價格 53.58 美元出售，總價值為 3,214,800.00 美元。交易完成後，該內部人士直接持有該公司 169,940 股股票，價值約 9,105,385.20 美元。這代表其持股減少了 26.09%。該交易在向證券交易委員會提交的文件中披露，文件可通過此鏈接訪問。此外，首席執行官 Andrew Dudum 於 8 月 7 日星期四出售了 660,000 股該公司的股票。股票以平均價格 50.58 美元出售，總交易額為 33,382,800.00 美元。交易完成後，首席執行官直接持有該公司 2,214,769 股股票，價值約 112,023,016.02 美元。該交易使其持股減少了 22.96%。該交易的披露信息可以在這裏找到。內部人士在上個季度共出售了 1,395,428 股公司股票，價值 71,753,898 美元。當前公司內部人士持有 13.71% 的股份。</p>
</div><h2>Hims &amp; Hers Health Profile</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 概況</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Hims &amp; Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人員連接，使他們能夠獲得心理健康、性健康、皮膚病和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Hims &amp; Hers Health</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>Engines to AI: Cummins’ Surprising Growth Driver</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>Smaller Industrials Names Seeing Surging Growth: Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Hims &amp; Hers Health</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>DICKS 體育用品公司的股票在財報發佈後下跌——這是一隻值得購買的股票嗎？</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
<li>AI 引擎：康明斯意外的增長驅動因素</li>
<li>除息日對投資者的重要性是什麼？</li>
<li>小型工業公司正在經歷快速增長：原因在這裏</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HIMS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims &amp; Hers Health, Inc. (NYSE:HIMS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 HIMS 感興趣的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取 Hims &amp; Hers Health, Inc. (NYSE:HIMS - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhJTVM" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HIMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Hims &amp; Hers Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Hims &amp; Hers Health 嗎？</h2>
</div><p>Before you consider Hims &amp; Hers Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims &amp; Hers Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 Hims &amp; Hers Health 並不在名單上。</p>
</div><p>While Hims &amp; Hers Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Hims &amp; Hers Health 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Trexquant Investment LP 出售了 262,607 股 Hims & Hers Health, Inc.的股票，股票代碼為$HIMS